Clinical Trial Update: A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers. [Phase 1, Phase 2]

View source ↗

Summary

BeiGene reports a Phase 1/2 trial evaluating the safety of novel dose ramp-up schedules for Sonrotoclax in chronic lymphocytic leukemia; the study is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Sonrotoclax

Snippet

Sponsor: BeiGene | Conditions: Chronic Lymphocytic Leukemia, CLL | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING